| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 8
| Issue : 1 | Page : 25 |
|
|
Comparison of dosimetric parameters and three-dimensional dosimetric verification of three intensity-modulated radiotherapy plans for thymoma based on the dose–volume histogram and ArcCHECK-3DVH system
Peng Zhou, Jia Luo, He Xiao, Mingying Geng, Xuan He
Department of Cancer Center, Daping Hospital, Army Medical University, Chongqing, China
Correspondence Address:
Mingying Geng
Department of Cancer Center, Daping Hospital, Army Medical University, No. 10 Changjiang Zhilu, Yuzhong District, Chongqing 400042
China
Xuan He
Department of Cancer Center, Daping Hospital, Army Medical University, No. 10 Changjiang Zhilu, Yuzhong District, Chongqing 400042
China
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/digm.digm_11_22
|
|
|
Objective: To compare the dosimetric parameters of step-shoot intensity-modulated radiotherapy (sIMRT), dynamic intensity-modulated radiotherapy (dIMRT), and volume-modulated arc therapy (VMAT) in thymoma and to study the feasibility of the ArcCHECK-3DVH system in three intensity-modulated radiotherapy plans to choose a more appropriate intensity-modulated radiotherapy for thymoma. Materials and Methods: Seventeen patients with thymoma were enrolled in this study. Treatment plans of sIMRT, dIMRT, and VMAT for each patient were based on the Monaco treatment planning system (TPS). Dosimetric verification was performed via the ArcCHECK-3DVH system. We compared and analyzed the 3D γ pass rates of the TPS dose calculation and ArcCHECK-3DVH system dose reconstruction with the three gamma criteria (3 mm/3%, 2 mm/2%, and 1 mm/1%) with a threshold of 10%. Dose–volume histogram analysis was used to compare the dose parameters for target volumes, and organs at risk (OARs), such as D98%, D50%, D2%, Dmax, V20, and V5. Monitor units (MUs) and delivery time were also compared. Results: There were significant differences in the three intensity-modulated radiotherapy plans. For target volume, VMAT showed the highest planning target volume (PTV) D98% and the lowest PTV D50% compared with sIMRT or dIMRT. The PTV D2% of VMAT was lower than that of sIMRT and higher than that of dIMRT, and VAMT demonstrated the highest conformity index and MU, lowest homogeneity index, and shortest treatment delivery time. For the OARs, VMAT is not inferior to sIMRT and dIMRT in OARs protection. For the dosimetric verification, the entire area, PTV, lungs, heart, and spinal cord of VMAT showed the highest γ pass rates than the other two techniques under the gamma 3 mm/3% criteria, which was even more pronounced when the stricter gamma criteria of 2 mm/2% and 1 mm/1% were applied. Conclusion: VMAT can be applied to radiotherapy of thymoma, and the accuracy of treatment plan execution can be guaranteed through the ArcCHECK-3DVH system.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
